RecruitingPhase 1NCT06614010

Effect of Different Administration Routes of Dexmedetomidine Combined with Ultrasound-Guided Fascia Iliaca Block on Emergence Agitation After Hip Replacement Surgery


Sponsor

Qianfoshan Hospital

Enrollment

207 participants

Start Date

Feb 5, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

To examine the impact of various administration routes of dexmedetomidine in conjunction with ultrasound-guided fascia iliaca block (FIB) on emergence agitation (EA) during the postoperative recovery period after hip replacement surgery.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria6

  • age between 18 and 65 years, with no restriction on gender
  • diagnosis of hip joint disease necessitating hip arthroplasty
  • ASA grade I-II
  • no significant cardiopulmonary, hepatic, or renal dysfunction prior to the operation
  • no history of psychiatric disorders or long-term use of sedative medications prior to the operation
  • signing of an informed consent form to voluntarily participate in the study.

Exclusion Criteria7

  • patients allergic to or with contraindications to ropivacaine or dexmedetomidine
  • patients exhibiting symptoms of agitation or delirium prior to the procedure
  • patients with severe central or peripheral nervous system disorders
  • patients with coagulation disorders or receiving anticoagulant therapy
  • pregnant or breastfeeding women
  • patients who received other medications or treatments prior to the procedure that might affect the study results
  • patients unable to cooperate with the study or intolerant to ultrasound-guided iliofascial block

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDexmedetomidine Injection

Before anesthesia induction, an iliac fascia block was administered using 0.375% ropivacaine (30 mL) under ultrasound guidance, followed by conventional anesthesia induction. During the anesthesia maintenance phase, dexmedetomidine was infused intravenously at a rate of 0.5 µg/kg/h.

DRUGRopivacaine and Dexmedetomidine

Before anesthesia induction, an iliac fascia block was administered using a mixture of 0.375% ropivacaine and 1ug/kg dexmedetomidine (30ml) under ultrasound guidance. During the anesthesia maintenance phase, an equivalent volume of 0.9% sodium chloride injection was infused intravenously.

DRUGSodium Chloride Injection

Before anesthesia induction, an iliac fascia block was performed using 0.375% ropivacaine (30 mL) under ultrasound guidance, followed by conventional anesthesia induction. During the anesthesia maintenance phase, an equivalent volume of 0.9% sodium chloride injection was infused intravenously.


Locations(1)

Qianfoshan Hospital

Jinan, Shandong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06614010


Related Trials